Clinical Trials Browser

OTHER × Multiple Myeloma × Patient Reported Outcome Measures × Clear all

COVID-19, Multiple Myeloma, Neoplasms, Plasma Cell

NCT07558057 2026-04-30

COGNITOX

Not yet recruiting

225 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell, Marginal Zone

NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

Phase NA Unknown

30 enrolled

LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

Clinical Trials

COSMIC

COGNITOX

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence